Skip to main content
Nanoscale Research Letters
Nanoscale Research Letters Cover Image

Table 1 The effect of the different ratio of drug to lipid on the SLN characteristic

From: Oral Administration of Resveratrol-Loaded Solid Lipid Nanoparticle Improves Insulin Resistance Through Targeting Expression of SNARE Proteins in Adipose and Muscle Tissue in Rats with Type 2 Diabetes

Formulation name RES (mg) Average size (nm) PDI ZP (mV) EE (%)
SLN 0 219.7 0.480 − 16.1 –
SLN-RES-30 30 257.6 0.447 − 17.7 64.3
SLN-RES-50 50 248.3 0.422 − 16.5 79.7
SLN-RES-70 70 224.3 0.474 − 17.3 60.1
  1. SLN-RES-30, 50, and 70 nanoparticle formulation containing 30, 50, and 70 mg of resveratrol, RES pure resveratrol powder, PDI polydispersity index, ZP zeta potential, EE entrapment efficiency
Back to article page